Biphenyl-2-carbonitrile (5d)7h. 1H NMR (400 MHz, CDCl3) d
7.75 (d, J = 8.0 Hz, 1H), 7.63 (t, J = 8.0 Hz, 1H), 7.55 (d, J =
8.0 Hz, 2H), 7.53–7.42 (m, 5H); 13C NMR (100 MHz, CDCl3) d
145.9, 138.6, 134.1, 133.2, 130.5, 129.2, 129.1, 127.9, 119.1, 111.8;
MS (CI, m/z,%) 180 (100) [M+H]+; Anal. calcd for C13H9N: C,
87.12; H, 5.06; N, 7.82. Found: C, 87.20; H, 5.00; N, 7.80.
2-Methoxy-1,1¢-binaphthyl (5m)23. 1H NMR (400 MHz,
CDCl3) d 7.95 (d, J = 8.8 Hz, 1H), 7.94–7.90 (m, 2H), 7.84 (d,
J = 8.4 Hz, 1H), 7.59 (dd, J = 8.4, 6.8 Hz, 1H), 7.44–7.40 (m,
3H), 7.33–7.30 (m, 2H), 7.29–7.13 (m, 3H), 3.73 (s, 3H); 13C NMR
(100 MHz, CDCl3) d 155.1, 135.0, 134.7, 134.2, 133.4, 129.9, 129.5,
128.9, 128.7, 128.2, 128.1, 126.8, 126.6, 126.3, 126.1, 126.0, 125.9,
124.0, 123.8, 114.4, 57.2; MS (CI, m/z,%) 285 (100) [M+H]+;
Anal. calcd for C21H16O: C, 88.70; H, 5.67. Found: C, 88.77;
H, 5.64.
3-Methoxybiphenyl (5e)20. 1H NMR (400 MHz, CDCl3) d 7.58
(d, J = 8.0 Hz, 2H), 7.42 (t, J = 8.0 Hz, 2H), 7.37–7.32 (m, 2H),
7.18 (d, J = 7.2 Hz, 1H), 7.12 (s, 1H), 6.90 (d, J = 7.2 Hz, 1H),
3.86 (s, 3H); 13C NMR (100 MHz, CDCl3) d 160.4, 143.2, 141.6,
130.1, 129.1, 127.8, 127.6, 120.1, 113.4, 113.1, 55.7; MS (CI, m/z,
%) 185 (100) [M+H]+; Anal. calcd for C13H12O: C, 84.75; H, 6.57.
Found: C, 84.70; H, 6.67.
Acknowledgements
We gratefully acknowledge the DTI MMI project and its in-
dustrial/academic partners (Prof. R. Catlow, Royal Institution;
Dr. A. Danopoulos, University of Southampton; Dr. A. Pettman,
Pfizer; Dr. P. Hogan and Dr. M. Purdie, AstraZeneca; Dr.
P. Ravenscroft, GlaxoSmithKline) for financial support and
valuable suggestions.
4-Methylbiphenyl (5f)7h. 1H NMR (400 MHz, CDCl3) d 7.57
(d, J = 7.6 Hz, 2H), 7.49 (d, J = 8.0 Hz, 2H), 7.41 (t, J = 7.6 Hz,
2H), 7.35–7.29 (m, 1H), 7.24 (d, J = 7.6 Hz, 2H), 2.39 (s, 3H);
13C NMR (100 MHz, CDCl3) d 141.6, 138.8, 137.4, 129.9, 129.2,
129.1, 127.5, 127.4, 21.5; MS (CI, m/z,%) 168 (100) [M]+; Anal.
calcd for C13H12: C, 92.81; H, 7.19. Found: C, 92.71; H, 7.17.
References
1 (a) Metal-Catalyzed Cross-Coupling Reactions, eds. A. de Meijere and
F. Diederich, Wiley-VCH, Weinheim, 2nd edn, 2004; (b) J. Tsuji,
Palladium Reagents and Catalysts, Wiley, Chichester, 2nd edn, 2004;
(c) Handbook of Organopalladium Chemistry for Organic Synthesis, ed.
E.-I. Negishi, Wiley Interscience, New York, 2002.
2 For recent reviews, see: (a) R. Martin and S. L. Buchwald, Acc. Chem.
Res., 2008, 41, 1461; (b) N. Marion and S. P. Nolan, Acc. Chem. Res.,
2008, 41, 1440; (c) F. Alonso, I. P. Beletskaya and M. Yus, Tetrahedron,
2008, 64, 3047; (d) N. T. S. Phan, M. Van Der Sluys and C. W. Jones,
Adv. Synth. Catal., 2006, 348, 609; (e) A. Suzuki, in Boronic Acids:
Preparation and Applications in Organic Synthesis and Medicine, ed.
D. G. Hall, Wiley-VCH, Weinheim, 2005, Chapter 3; (f) N. Miyaura,
in Metal-Catalyzed Cross-Coupling Reactions, eds. A. de Meijere and
F. Diederich, Wiley-VCH, Weinheim, 2nd edn, 2004, Vol. 1, Chapter 2;
(g) A. Suzuki, in Modern Arene Chemistry, ed. D. Astruc, Wiley-VCH,
Weinheim, 2002, Chapter 3.
3 For recent reviews, see: (a) J. F. Hartwig, Acc. Chem. Res., 2008, 41,
1534; (b) D. S. Surry and S. L. Buchwald, Angew. Chem., Int. Ed., 2008,
47, 6338; (c) J. F. Hartwig, Synlett, 2006, 1283; (d) A. R. Muci and S. L.
Buchwald, Top. Curr. Chem., 2002, 219, 131; (e) J. F. Hartwig, Modern
Arene Chemistry, 2002, D.Astruc, Wiley-VCH, Weinheim, Chapter 4;
(f) J. P. Wolfe, S. Wagaw, J.-F. Marcoux and S. L. Buchwald, Acc. Chem.
Res., 1998, 31, 805.
4 For a review on Pd-catalyzed couplings reactions of aryl chlorides, see:
A. F. Littke and G. C. Fu, Angew. Chem., Int. Ed., 2002, 41, 4176.
5 (a) V. V. Grushin and H. Alper, in Activation of Unreactive Bonds and
Organic Synthesis, ed. S. Murai, Springer, Berlin, 1999, pp. 193–226;
(b) V. V. Grushin and H. Alper, Chem. Rev., 1994, 94, 1047.
6 For some recent examples of Suzuki-Miyaura coupling using aryl
chlorides, see: (a) K. L. Billingsley, T. E. Barder and S. L. Buchwald,
Angew. Chem., Int. Ed., 2007, 46, 5359; (b) C. M. So, C. P. Lau and
F. Y. Kwong, Org. Lett., 2007, 9, 2795; (c) M. Thimmaiah and S. Fang,
Tetrahedron, 2007, 63, 6879; (d) S.-D. Cho, H.-K. Kim, H.-S. Yim,
M.-R. Kim, J.-K. Lee, J.-J. Kim and Y.-J. Yoon, Tetrahedron, 2007, 63,
1345; (e) S Teo, Z. Weng and T. S. A. Hor, Organometallics, 2006, 25,
1199; (f) T. E. Barder, S. D. Walker, J. R. Martinelli and S. L. Buchwald,
J. Am. Chem. Soc., 2005, 127, 4685; (g) D. Liu, W. Gao, Q. Dai and
X. Zhang, Org. Lett., 2005, 7, 4907; (h) A. Zapf and M. Beller, Chem.
Commun., 2005, 431; (i) J. Lemo, K. Heuze and D. Astruc, Org. Lett.,
2005, 7, 2253.
7 For some recent examples of Buchwald–Hartwig amination reaction
using aryl chlorides, see: (a) B. P. Fors, D. A. Watson, M. R. Biscoe and
S. L. Buchwald, J. Am. Chem. Soc., 2008, 130, 13552; (b) M. R. Biscoe,
B. P. Fors and S. L. Buchwald, J. Am. Chem. Soc., 2008, 130, 6686; (c) Q.
Shen, T. Ogata and J. F. Hartwig, J. Am. Chem. Soc., 2008, 130, 6586;
(d) K. Suzuki, Y. Hori and T. Kobayashia, Adv. Synth. Catal., 2008,
350, 652; (e) M. R. Biscoe, T. E. Barder and S. L. Buchwald, Angew.
Chem., Int. Ed., 2007, 46, 7232; (f) T. Ikawa, T. E. Barder, M. R. Biscoe
and S. L. Buchwald, J. Am. Chem. Soc., 2007, 129, 13001; (g) X. Xie,
4-Methoxybiphenyl (5g)15. 1H NMR (400 MHz, CDCl3) d
7.56–7.50 (m, 4H), 7.43–7.38 (m, 2H), 7.32–7.28 (m, 1H), 6.97
(d, J = 8.4 Hz, 2H), 3.85 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 159.6, 141.3, 134.2, 129.1, 128.6, 127.1, 127.0, 114.6, 55.7; MS
(CI, m/z,%) 185 (100) [M+H]+; Anal. calcd for C13H12O: C, 84.75;
H, 6.57. Found: C, 84.80; H, 6.57.
Biphenyl-4-carbonitrile (5h)21. 1H NMR (400 MHz, CDCl3) d
7.72 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.59 (d, J =
7.6 Hz, 2H), 7.51–7.46 (m, 2H), 7.42 (d, J = 7.2 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 146.1, 139.6, 133.0, 129.5, 129.1, 128.1, 127.6,
119.3, 111.4; MS (CI, m/z,%) 180 (100) [M+H]+; Anal. calcd for
C13H9N: C, 87.12; H, 5.06; N, 7.82. Found: C, 87.05; H, 5.01; N,
7.94.
4-Acetylbiphenyl (5i)22. 1H NMR (400 MHz, CDCl3) d 8.02
(d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 7.6 Hz,
2H), 7.49–7.44 (m, 2H), 7.42–7.37 (m, 1H), 2.63 (s, 3H); 13C NMR
(100 MHz, CDCl3) d 198.1, 146.2, 140.3, 136.3, 129.4, 129.3, 128.6,
127.7, 127.6, 27.0; MS (CI, m/z,%) 197 (100) [M+H]+; Anal. calcd
for C14H12O: C, 85.68; H, 6.16. Found: C, 85.53; H, 6.14.
2,6-Dimethylbiphenyl (5j)22. 1H NMR (400 MHz, CDCl3) d
7.42 (t, J = 7.6 Hz, 2H), 7.35–7.31 (m, 1H), 7.16–7.09 (m, 5H),
2.03 (s, 6H); 13C NMR (100 MHz, CDCl3) d 142.3, 141.5, 136.4,
129.4, 128.8, 127.7, 127.4, 127.0, 21.2; MS (CI, m/z,%) 182 (100)
[M]+; Anal. calcd for C14H14: C, 92.26; H, 7.74. Found: C, 92.38;
H, 7.68.
4,4¢-Dimethoxybiphenyl (5k)21. 1H NMR (400 MHz, CDCl3)
d 7.59 (d, J = 8.8 Hz, 4H), 6.95 (d, J = 8.8 Hz, 4H), 3.84 (s, 6H);
13C NMR (100 MHz, CDCl3) d 159.2, 133.9, 128.1, 114.6, 55.7;
MS (CI, m/z,%) 215 (100) [M+H]+; Anal. calcd for C14H14O2: C,
78.48; H, 6.59. Found: C, 78.37; H, 6.64.
2,2¢-Dimethylbiphenyl (5l)16. 1H NMR (400 MHz, CDCl3) d
7.26–7.19 (m, 6H), 7.09 (d, J = 7.2 Hz, 2H), 2.05 (s, 6H); 13C NMR
(100 MHz, CDCl3) d 142.1, 136.2, 130.2, 129.7, 127.6, 126.0, 20.2;
MS (CI, m/z,%) 182 (100) [M]+; Anal. calcd for C14H14: C, 92.26;
H, 7.74. Found: C, 92.09; H, 7.78.
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 3236–3242 | 3241
©